Endometriosis-associated obstructive uropathy: A case report

Caoimhe Ryan, Clióna Ryan, Michael Burns, Michael J. Burns, Lynn Redahan
SAGE open medical case reports · 2025 · vol. 13 , pp. 2050313X251321671 · doi:10.1177/2050313x251321671 · PMID:39967608 · PMC11833833 · W4407706907
case-report OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This case report describes a patient with stage IV endometriosis and HIV who presented with severe bilateral hydronephrosis and kidney injury due to urinary tract obstruction, successfully managed non-surgically.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis affects approximately 10% of premenopausal women, with urinary tract involvement in 1% of cases. Ureteric endometriosis is a rare, typically asymptomatic, cause of obstructive renal failure. We present the case of a 30-year-old woman with stage IV endometriosis and advanced human immunodeficiency virus presenting with acute, severe left flank pain and kidney injury. Imaging revealed severe, bilateral hydronephrosis due to extensive endometriosis deposits obstructing the urinary tract. Recurrent ureteric obstruction by infiltrating endometrial disease necessitated eight procedures (bilateral nephroureteric stent placements and nephrostomy insertions). Despite the severity of the disease surgery was successfully avoided. At the time of discharge and subsequent follow-up, the patient was clinically well with stable renal function (Creatinine 1.33-1.61 mg/dL). This case highlights the importance of considering endometriosis in the differential diagnosis of acute kidney injury in women. It demonstrates successful non-surgical management of severe ureteric disease to prevent irreversible renal damage.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (22)

Source provenance

europepmc
last seen: 2026-06-13T17:20:28.795615+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-06-13T17:17:28.734484+00:00
License: CC0 · commercial use OK